Oxidative stress in Alzheimer patients in different stages of the disease

Current Medicinal Chemistry

Volumn 13, Issue 9, 2006, Pages 1075-1083

  Zafrilla, P ^a   Mulero, J ^a   Xandri, J M ^b   Santo, E ^c   Caravaca, G ^a   Morillas, J M ^a  

^a CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c Residencia Geriatrica San Basilio   (Spain)

Author keywords

Alzheimer's disease; Free radicals; Glutathione peroxidase; Glutathione reductase; Malondialdehyde; Oxidative stress; Protein modifications; Superoxide dismutase

Indexed keywords

ALBUMIN; BILIRUBIN; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

AGED; ALBUMIN BLOOD LEVEL; ALZHEIMER DISEASE; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; BILIRUBIN BLOOD LEVEL; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GERIATRIC DISORDER; GERIATRIC PATIENT; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NUTRITIONAL ASSESSMENT; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STAGING; URIC ACID BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPID PEROXIDATION; MALE; NUTRITION PHYSIOLOGY; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33645979958     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986706776360978     Document Type: Review

References (61)

1. Gabryelewicz, T. Neurol. Neurochi. Pol. Suppl., 1999, 1, 11
2. Benzi, G.; Moretti, A. Neurobiol. Aging, 1995, 16, 661
3. Ames, B.; Shingenaga, M.; Park, E.M. Oxidation damage and repair: chemical, biological and medical aspects. Elmsford, United Kingdom: Pergamon Press, 1991.
4. Cooper, A.J.L. In The molecular and genetic basis of neurological disease: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Klunk LM, eds. Boston, Butterworth-Heinemann, 1997, 1242.
5. Hazel, J.R.; Williams, E.E. Prog. Lipid. Res., 1990, 29, 167.
6. Smith, M.A.; Rudnicka-Nawrot, M.; Richey, P.L.; Praprotnik, D.; Mulvihill, P.; Miller, C.A.; Sayre, L.M.; Perry, G. J. Neurochem., 1995, 64, 2660.
7. Beyreuther, K.; Bush, A.I.; Dyrks, T.; Hilbich, C.; Konig, G.; Monning, U.; Multhaup, G.; Prior, R.; Rumble, B.; Schubert, W. Ann. N.Y. Acad. Sci., 1991, 640, 129.
8. Selkoe, D.J. J. Biol. Chem., 1996, 27, 18295.
9. Atwood, C.S.; Scarpa, R.C.; Huang, X.; Moir, R.D.; Jones, W.D.; Fairlie, D.P.; Tanzi, R.E. J. Neurochem., 2000, 75, 1219.
10. Christen, Y.; Am. J. Clin Nutr., 2000, 71, 621S.
11. Sayre, L.M.; Perry, G.; Harris, P.L.R.; Liu, Y.; Schubert, K.A.; Smith, M.A. J. Neurochem., 2000, 74, 270.
12. Stadtman, E.R.; Berlett, B.S. Chem. Res. Toxicol., 1997, 10, 485.
13. Butterfield, D. A. Chem. Res. Toxicol., 1997, 10, 495.
14. Mattson, M.P. Alzheimer' Dis. Rev., 1997, 2, 1.
15. Yuan, J.; Yankner, B.A. Nature, 2000, 407, 802.
16. Nitsch, R.M.; Blusztajn, J.K.; Pittas, A.G.; Slack, B.E.; Growdon, J.H.; Wurtman, R.J. Proc. Nat. Acad. Sci. USA, 1992; 89, 1671.
17. Markesbery, W.R. Free Radic. Biol. Med., 1997, 23 (1), 134.
18. Markesbery, W.R.; Lovell, M.A. Neurobiol. Aging, 1998, 19, 33.
19. Dugan, L.L.; Sensi, S.L.; Canzoniero, L.M.T, Handran, S.D.; Rothman, S.M.; Lin, T.T.; Goldberg, M.P.; Choi, D.W. J. Neurosci., 1995, 15, 6377.
20. Reynolds, I.J.; Hastings, T.G. J. Neurosci., 1995, 15, 3318.
21. Ramassamy, C.; Krzywokowski, P.; Bastianetto, S; et al. In Alzheimer's disease brain. Packer, L.; Christen, Y, ed.; Elsevier: Paris, 1998; pp. 69-83.
22. Piani, D.; Frei, K.; Do, K.Q.; Cuenod, M.; Fontana, A. Neurosci. Lett., 1991, 133, 159.
23. Kosaka, T.; Imagawa, M.; Seki, K.; Arai, H.; Sasaki, H.; Tsuji, S.; Asami-Odaka, A.; Fukushima, T.; Imai, K.; Iwatsubo, T. Neurology., 1997, 48, 741.
24. García-Ospina, G.; Jiménez Del Río, M.; Lopera, F.; Velez-Pardo, C. Rev. Neurol., 2003, 36(11), 1004.
25. Imenez Del Rio, M.; Velez-Pardo, C. Arch. Med. Res., 2004, 35(3), 185.
26. Pappola, M.A.; Sos, M.; Omar, R.A.; Sambamurti, K. Mol. Chem. Neuropathol., 1996, 28, 21.
27. Santos, F.; Chart, J.C.M.; Yang, M.S.; Savory, J.; Wills, M.R. Med. Biol., 1987, 65, 53.
28. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E.M. Neurology, 1984, 34, 939-944.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. Washington, DC, USA: APA Press, 1987.
30. Folstein, M.F.; Folstein, S.E.; McHugh, P.R. M J. Psychiatr. Res., 1975, 12, 189
31. Chirico, S. Methods Enzymol., 1994, 233, 314.
32. Miller, N.J, Rice-Evans C, Davies ML, Gopinathan V, Milner A. Clin. Sci., 1993, 84, 407.
33. Plagia, D.E.; Valentine, W.N. J. Lab. Clin. Med., 1967, 70, 158.
34. Anderson, J. W., Foyer, C. H.; Walker, D. A. Planta., 1983, 158, 442.
35. Delmas-Beauvieux, M.C.; Peuchant, E.; Couchouron, A. Am. J. Clin. Nutr., 1996, 64, 101.
36. Evans, P.; Lyras, L.; Haliwell, B. Methods Enzymol., 1999, 300, 145.
37. Levine, R.L.; Williams, J.A.; Stadman, E.R.; Shacter, E. Methods Enzymol., 1994, 233, 346.
38. Reznick, A.Z.; Packer, L. Methods Enzymol., 1994, 233, 357.
39. Ceballos-Picot, I.; Merd-Boudia, M.; Nicole, A. Free Radic Biol Med., 1996, 20, 579.
40. Hensey, K.; Hall, N.; Subramaniam, R. J. Neurochem., 1995, 65, 2146.
41. Smith, M.A.; Sayre, L.M.; Anderson, V.E.; Harris, P.L.; Beal, M.F.; Kowall, N.; Perry, G. J. Histochem. Cytochem., 1998, 46(6), 731-735.
42. Potocki, L. Science, 2003, 299, 887.
43. Bourdel-Marchasson, I.; Delmas-Beauvieux, M.C.; Peuchant, E.; Richard-Harston, S.; Decamps, A.; Reignier, B.; Emeriau, J.P. Age Ageing, 2001, 30, 3, 235.
44. Delibas, N.; Ozcankaya, R.; Altuntas. Clin. Biochem., 2002, 35 (2), 137.
45. McGrath, L.T.; McGleenon, B.M.; Brennan, S.; McColl, D.; McILroy, S.; Passmore, A.P. Q. J. Med., 2001, 94, 485.
46. Hayn, M.; Kremser, K.; Singewald, N.; Cairns, N.; Nemethova, M.; Lubec, B.; Lubec, G. Life Sci., 1996, 59, 537.
47. Lyras, L.; Perry, R. H.; Perry, E. K.; Ince, P. G.; Jenner, A.; Jenner, P.; Halliwell, B. J. Neurochem., 1998, 71, 302.
48. Butterfield, D.A.; Kanski, J. Peptides, 2002, 23(7), 1299.
49. Praticò, D.; Clark, C.M.; Liun, F.; Lee, V.Y.M.; Trojanowski, J.Q. Arch Neurol., 2002, 59, 972.
50. Palmer, A.M.; Burns, M.A. Brain Res., 1994, 645, 338.
51. Marcus, D.L.; Thomas, C.; Rodríguez, C.; Simber- koff, K.; Tsai, J.S. Exp. Neurol., 1998, 150, 40.
52. Busciglio, J.;Yankner, B. A.;Nature, 1995, 378, 776.
53. Anneren, G.; Gardner, A.; Lundin, T. Acta Neurol. Scand., 1986, 73, 586.
54. Barkats M.; Millecamps, S.; Abrioux, P.; Geoffroy, M.; Mallet, J. J. Neurochem., 2000, 75, 1438.
55. Kish, S.J.; Morito, C.L.; Hornykiewicz, O. Neurochem. Pathol., 1986, 4(1), 23.
56. Lovell, M.A.; Ehmann, W.D.; Butler, S.M.; Markesbery, W.R. Neurology., 1995, 45, 1594.
57. Hara, Y.; Haybara, T.; Sasaki, K. J. Neurol. Sci., 1997, 153, 76.
58. Venarucci, D.; Venarucci, V.; Vallese, A.; Battila, L.; Casado, A.; De la Torre, R.; López Fernández, M.E. Panminerva Med., 1999, 41(4), 335.
59. Mecocci, P.; Polidori, C.; Cherubini, A.; Ingegni, T.; Mattioli, P.; Catani, M.; Rinaldi, P.; Cecchetti, R.; Stahl, W.; Senin, U.; Beal, F. Arch. Neurol., 2002, 59, 794.
60. Engelhart, M.J.; Geerlings, M.I.; Ruttenberg, A. Van-Swieten, J.C.; Hofman, A.; Witterman, J.C.M. Breteler, M.M. J. Amer. Med. Assoc., 2002, 3287, 3223.
61. Morris, M.C.; Evans, D.A.; Bilenias, J.L.; Tangney, C.C.; Bennet, D.A. Aggarwall, N.; Schneider, J.; Wilson, R.S. J. Amer. Med. Assoc., 2002, 287, 3230.